Altimmune, Inc.
ALT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$19 | -$22 | -$20 | -$23 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | -$1 | $0 |
| Stock-Based Comp. | $4 | $0 | $4 | $3 |
| Change in WC | $4 | -$0 | $0 | $2 |
| Other Non-Cash | $0 | $3 | -$1 | -$1 |
| Operating Cash Flow | -$12 | -$20 | -$17 | -$18 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$149 | -$4 | -$43 | -$13 |
| Inv. Sales/Matur. | $0 | $106 | $38 | $27 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$149 | $101 | -$5 | $14 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $15 | $0 | $0 |
| Stock Issued | $40 | $38 | $35 | $10 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | -$0 | -$1 | $0 |
| Financing Cash Flow | $39 | $53 | $34 | $10 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$122 | $134 | $12 | $5 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $183 | $49 | $37 | $32 |
| End Cash | $61 | $183 | $49 | $37 |
| Free Cash Flow | -$12 | -$20 | -$17 | -$18 |